The Serum Resistome Globally Disseminated
Multidrug Resistant Uropathogenic Escherichia coli
Clone
Minh-Duy Phan1,2, Kate M. Peters1,2, Sohinee Sarkar1,2, Samuel W. Lukowski3¤, Luke P. Allsopp1,2,
Danilo Gomes Moriel1,2, Maud E. S. Achard1,2, Makrina Totsika1,2, Vikki M. Marshall3, Mathew Upton4,
Scott  Beatson1,2, Mark  Schembri1,2*
1 Australian Infectious Diseases Research Centre, University Queensland, Brisbane, Queensland, Australia, 2 School Chemistry Molecular Biosciences, University Queensland, Brisbane, Queensland, Australia, 3 Queensland Brain Institute, University Queensland, Brisbane, Queensland, Australia, 4 Faculty Medicine Dentistry, University Plymouth, Plymouth, United Kingdom



     Abstract
     Escherichia coli ST131 globally disseminated, multidrug resistant clone responsible high proportion urinary tract
     bloodstream infections. rapid emergence successful spread E. coli ST131 strongly associated      antibiotic resistance;  phenotype unlikely explain dominance multidrug resistant
     uropathogens circulating worldwide hospitals community.  greater understanding molecular
     mechanisms underpin fitness E. coli ST131 required. study, employed hyper-saturated transposon
     mutagenesis combination multiplexed transposon directed insertion-site sequencing define essential genes
     required vitro growth serum resistome  e. genes required resistance human serum) E. coli EC958,      representative predominant E. coli ST131 clonal lineage. identified 315 essential genes E. coli EC958, 231 (73 )
     essential E. coli K-12. serum resistome comprised 56 genes, majority encode
     membrane proteins factors involved lipopolysaccharide (LPS) biosynthesis. Targeted mutagenesis confirmed role      serum resistance 46 (82 ) genes. murein lipoprotein Lpp, lipid core biosynthesis enzymes
     WaaP WaaG, strongly associated serum resistance. LPS main resistance mechanism
     defined E. coli EC958 serum, enterobacterial common antigen colanic acid impacted phenotype.
     analysis identified novel function genes, hyxA hyxR, minor regulators O-antigen chain length.
     study offers novel insight genetic make E. coli ST131, provides framework future research E.
     coli Gram-negative pathogens define essential gene repertoire dissect molecular mechanisms
     enable survive bloodstream cause disease.

  Citation: Phan M-D, Peters KM, Sarkar S, Lukowski SW, Allsopp LP, et al. (2013) Serum Resistome Globally Disseminated Multidrug Resistant
  Uropathogenic Escherichia coli Clone. PLoS Genet 9(10): e1003834. doi:10.1371/journal.pgen.1003834
  Editor: Paul M. Richardson, MicroTrek Incorporated, United States America
  Received April 11, 2013; Accepted August 12, 2013; Published October 3, 2013
  Copyright: ß 2013 Phan et al. open-access article distributed terms Creative Commons Attribution License, permits
  unrestricted use, distribution, reproduction medium, provided original author source credited.
  Funding: work supported grant Australian National Health Medical Research Council [APP1012076]. MAS supported   Australian Research Council (ARC) Future Fellowship [FT100100662]. SAB supported ARC Australian Research Fellowship [DP0881347]. MT   supported ARC Discovery Early Career Researcher Award [DE130101169]. funders role study design, data collection analysis, decision   publish, preparation manuscript.
  Competing Interests: authors declared competing interests exist.
  * E-mail: m.schembri@uq.edu.au
  ¤ Current address: Department Genetic Medicine Development, University Geneva, Geneva, Switzerland.




Introduction                                                                         fluoroquinolones [3,10].  fluoroquinolone-resistant E.
                                                                                     coli strains belong recently emerged dominant subgroup     Escherichia coli O25b:H4-ST131 (E. coli ST131) recently                     ST131 strains [11]. E. coli ST131 strains emerged, globally disseminated clone multidrug                         reported produce carbapenemases [12–14], severely
resistant responsible high proportion community-                     limiting treatment options currently available nosocomially-acquired urinary tract bloodstream infec-                       clinically predominant clone [15].
tions [1–6]. E. coli ST131 strains capable causing                          E. coli ST131 strains, like uropathogenic E. coli
complicated infections including acute pyelonephritis, osteomye-                     (UPEC) strains, derived phylogenetic group B2 [3].
litis, septic arthritis septic shock [7,8]. E. coli ST131                    Typically, UPEC strains possess large diverse range commonly associated production CTX-M-15 enzyme,                          virulence factors contribute ability cause urinary
currently widespread extended spectrum b-lactamase                          tract bloodstream infections, including adhesins, toxins,
(ESBL) type world [1,9]. addition resistance                     siderophores protectins [15,16]. studies demon- oxyimino-cephalosporins  e. cefotaxime, ceftazidime),                  strated E. coli ST131 strains possess similar suite virulence
monobactams, E. coli ST131 strains resistant                         factors cause invasive disease, leading hypothesis 

PLOS Genetics | www.plosgenetics.org                                             1                          October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                          Serum Resistome E. coli ST131 Strain



  Author Summary                                                              elements, little known combination factors                                                                               contribute resistance single strain.
  emergence rapid dissemination new bacterial                         High-throughput transposon mutagenesis combined ge-
  pathogens presents multiple challenges healthcare                        nome-wide targeted sequencing used recently study   systems, including need rapid detection, precise                    essential genes Salmonella enterica serovar Typhi Caulobacter
  diagnostics, effective transmission control effective                   crescentus [41,42]. Langridge et al. used transposon
  treatment. E. coli ST131 example recently                        directed insertion-site sequencing (TraDIS) method assay   emerged multidrug resistant pathogen capable                     gene role survival S. Typhi presence bile
  causing urinary tract bloodstream infections                                                                               salts [42]. Similar approaches (INSeq, HITS, Tn-seq)   limited available treatment options. order increase
                                                                              applied range organisms study gene requirements
  molecular understanding E. coli ST131, devel-
  oped high-throughput transposon mutagenesis                        survival particular niches [43–46].  adapted
  combination generation sequencing test                      TraDIS designed multiplexing method define   gene essential role growth                     essential genes required vitro growth  e. Luria-Bertani agar
  contribution serum resistance. identified 315                         media supplemented 30 mg/ml Cm 37uC) serum
  essential genes, 270 conserved                      resistome  e. genes required resistance human serum, E.
  currently available complete E. coli genomes. Fifty                     coli EC958). essential gene list E. coli EC958
  genes define serum resistome E. coli ST131                      comprises 315 genes, 231 shared E. coli K-12.
  identified, including genes encoding membrane                          define time comprehensive inventory   proteins, proteins involved LPS biosynthesis, regulators                 genes required resistance human serum. study provides
  novel proteins previously unknown                          molecular blueprint understanding mechanisms em-
  function. study provides inventory                     ployed E. coli ST131 survive, grow bloodstream   essential serum resistance genes form                      cause disease.
  framework future development targeted
  therapeutics prevent disease caused multidrug-
  resistant E. coli ST131 strains.                                            Results
                                                                              Application multiplexed TraDIS E. coli ST131 widespread pathogenic success E. coli ST131 strains                                                                               strain EC958 enhanced virulence [7,8,17].                        Approximately 1 million mutants generated E. coli clear recent studies E. coli ST131 strains            ST131 strain EC958 [22] using house miniTn5 transposon
possess heightened virulence potential compared UPEC               carrying chloramphenicol (Cm) resistance gene derived B2 E. coli strains causing invasive infections [18] infections       pKD3 plasmid [47]. primer comprising functional regions nematodes zebrafish embryos [19].  factors             designed facilitate specific sequencing transposon enhanced metabolic capacity proposed contribute               insertion sites Illumina HiSeq 2000 platform allowing fitness pathogenic success dominant clone                  intra-lane multiple sample indexing (Figure S1). primer
[20,21].                                                                      contained (59-39):   P5 sequence bind TruSeq flowcells,
   genome sequence best-characterized E. coli               (ii) Illumina read 1 sequencing primer binding site, (iii) 6-bp
ST131 strains, EC958, recently described [22]. E. coli EC958              index sequence multiple sample barcoding (iv) 25-bp member pulsed-field gel electrophoresis (PFGE) defined            transposon specific sequence designed amplify 12 bp UK epidemic strain  represents major                       transposon adjacent genomic sequence. Using pathogenic lineages (PFGE strains E) ESBL producing E. coli              custom primer, successfully sequenced transposon insertion
causing urinary tract infections (UTI) UK [23]. E. coli            sites 6 samples TruSeq version 2 version 3
EC958 resistant antibiotic classes, including oxyimino-           flowcells (Figure 1A). sample yielded 6.8 million 15
cephalosporins, fluoroquinolones sulphonamides. E. coli                   million reads tagged transposon specific sequence,
EC958 colonizes bladder mice type 1 fimbriae-                     71  reliably mapped EC958 draft chromosome
dependent manner [22], invade bladder epithelial cells               (excluding unscaffolded contigs plasmids) (Table 1). form intracellular bacterial communities, establish              experiments performed duplicate, correlation
acute chronic UTI [24] inhibit contraction                 coefficient number insertions gene pair ureters, vitro [25].                                                       samples close 1 (R2.0.99) demonstrating high level
   ability resist bactericidal activity serum,         reproducibility experiment (Figure 1B).
survive bloodstream, represents essential virulence trait UPEC extra-intestinal E. coli (ExPEC) strains,                  Essential genes E. coli EC958
including E. coli ST131 [26–28]. E. coli, mechanisms                  initially used saturated random insertion mutant library shown contribute serum resistance.                        determine ‘essential genes EC958’, defined set importance O-antigens K capsules resistance serum                genes required growth LB agar supplemented Cm recognized 1960s 1980s, respectively [29–              30 mg/ml. extracted genomic DNA  duplicates: input 31]; multiple types, combinations length contribute             B) directly library pool sequenced using differently serum resistance [32–35]. major outer                      multiplexed TraDIS protocol. combined reads input
membrane protein OmpA [36], plasmid-encoded proteins TraT                     B maximize coverage resulting 16 million
[37,38] Iss [39], phage membrane protein Bor [40]                 transposon-tagged reads, 11 million uniquely mapped reported contribute serum resistance E. coli.         EC958 chromosome, resulting 502,068 unique insertion
Notably, resistance mechanisms studied              sites. equates average insertion site isolation different strain backgrounds.  serum              9.92 bp, low probability having 100 consecutive bp
resistance clearly complex phenotype determined multiple              interruption chance (P = 4.261025).


PLOS Genetics | www.plosgenetics.org                                      2                      October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                           Serum Resistome E. coli ST131 Strain




Figure 1. Summary sequence read data multiplexed TraDIS.   Number tagged reads obtained lane TruSeq version 2 version 3 flowcells. (B) Correlation biological replicates. number insertions gene Test plotted Test B; correlation coefficient R2 indicates low variation replicates.
doi:10.1371/journal.pgen.1003834.g001

   essential gene list identified using statistical analysis          investigated. additional 17 proteins present similar described Langridge et al., recognized             90  genomes. 6 proteins specific EC958
distinct distributions insertion indexes (number insertions                50 genomes) (Table S3).
divided gene length) non-essential genes (gamma) essential genes (exponential) called insertion                   serum resistome E. coli EC958
indexes equal intercept distributions               Saturated transposon mutagenesis combination  essential [42]. data, insertion index cut 0.0158,           generation sequencing powerful tool genome, high-
resulted identification 315 genes essential (Table S1).            throughput identification candidate genes involved cut equivalent log2-likelihood-ratio (LLR) 23.6,            particular phenotype.  used transposon mutant means essential genes 12 times                 library combination TraDIS identify genes EC958
likely belong exponential distribution (essential)           involved resistance human serum, enabling define
gamma (non-essential) distribution.                                             serum resistome EC958. designed mutant selection
   functional category gene identified based                 procedure 1 million mutants exposed pooled COG (Clusters Orthologous Groups) numbers                       fresh human serum 90 minutes allowed grow LB
EC958 annotation (accession number PRJEA61443). Figure 2                        broth 4 hours genomic DNA extraction. procedure
shows overview essential functions EC958 compared                 permitted growth serum resistant mutants eliminating total number genes functional category. Genes                    inhibiting mutants sensitive serum (Figure 3A). involved translation, ribosomal structure biogenesis account             procedure performed parallel control samples 25  total number essential genes EC958,               fresh serum replaced inactivated serum lacked
42  total number genes category. second                   bactericidal activity (data shown). genomic DNA abundant category essential gene list comprised genes               test control samples sequenced using modified
involved cell wall/membrane/envelope biogenesis (12 ),                       Illumina multiplexed TraDIS procedure (Figure 3B) generate
followed genes involved coenzyme transport metabo-                    multiple datasets (Figure 1A) analysed lism. 23 essential genes functions identified            Bioconductor package edgeR filtering genes identified COG database.                                                               essential [48].
   investigate conservation EC958 essential proteins                     serum resistance genes identified genes different E. coli pathotypes, performed tfastx alignment               significant reduction read counts test samples compared
(FASTA v36) essential protein sequences                         control samples  e. mutants survived serum
translated DNA 50 E. coli complete genomes (Table S2).                     treatment) (Table S4). stringent threshold log2 fold change 270 (86 ) proteins conserved genomes                      read counts (logFC) 21 adjusted p-value 
 Table 1. Summary sequencing mapping results multiplexed TraDIS runs.


                               Tagged reads                Reads mapped EC958 chromosome ( )             Unique insertion sites EC958

 Input & B                   16,281,107                  11,558,154 (70.99)                               502,068
   Test                      6,819,691                   4,879,098 (71.54)                                438,706
   Test B                      7,572,730                   5,408,136 (71.41)                                436,858
   Ctrl                      8,350,687                   5,918,766 (70.87)                                394,521
   Ctrl B                      15,006,139                  10,727,954 (71.49)                               485,459

 doi:10.1371/journal.pgen.1003834.t001



PLOS Genetics | www.plosgenetics.org                                       3                       October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                      Serum Resistome E. coli ST131 Strain




Figure 2. Number essential genes COG functional category.
doi:10.1371/journal.pgen.1003834.g002


0.001 used identify significant genes involved          affect LPS rfaH (EC958_4322), encoding serum resistance (Figure S2). Figure 4 shows names                 known regulator required LPS biosynthesis [51,52] genomic locations 56 genes satisfied stringent           virulence pathogenic E. coli strains [53,54], whilst criteria.                                                                  represent genes previously shown    (39.3 ) genes belong operons                 associated serum resistance. murein lipoprotein gene lpp
responsible LPS biosynthesis (including O-antigen                 (EC958_1897) showed greatest difference test biosynthesis lipid core biosynthesis) enterobacterial            control samples (logFC 210), followed pgm (EC958_0806),
common antigen (ECA) biosynthesis. result represents              encoding phosphoglucomutase. hypothetical proteins layer evidence demonstrating importance O25            identified, (EC958_0460 EC958_0461)
antigen ECA E. coli ST131 background                  characterized study  .
protection bactericidal activity human serum.
Detailed characterisation O25 antigen gene cluster               Validation serum resistance genes
discussed subsequent sections. ECA common                        mentioned  employed stringent threshold
Enterobacteriaceae expressed serum resistant (smooth)       combining fold change statistical significance define sensitive (rough) strains, rough strains           set 56 genes EC958 serum resistome. order validate
defective shared biosynthesis pathway affecting O-             findings, attempted test 56 genes independently antigen ECA [49,50]. Seven 12 genes ECA                  role serum resistance. Using modified lambda red
operon required serum resistance determined             mediated-homologous recombination approach [22,47] suc-
TraDIS technique.                                                          cessfully generated defined knock mutants 54 genes
   remaining 60.7  genes serum resistome identified          (96.4 ) EC958. unable obtain mutants TraDIS included genes encoding lipoprotein, membrane                    remaining 2 genes (acrA EC958_2373) despite multiple
proteins, regulators hypothetical proteins (Table 2).          attempts (Table 2).


PLOS Genetics | www.plosgenetics.org                                   4                      October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                        Serum Resistome E. coli ST131 Strain




Figure 3. Experimental design identify serum resistance genes EC958.   Selection steps employed using fresh serum test inactivated serum control. (B) Schematic illustration Illumina sequencing procedure including use custom oligo indexing enrichment insert sites.
doi:10.1371/journal.pgen.1003834.g003




   54 defined mutants subjected serum susceptibility            O25b antigen biosynthesis genes conferring resistance testing, number surviving colonies 90-               serum
minute exposure fresh pooled human serum compared                    established O-antigen represents main number colonies prior treatment (Table 2). mutant           determinant serum resistance E. coli.  defined susceptible serum log difference        180 different O-antigens defined E.
1  e. 10 fold reduction exposure serum). genes         coli contribute differently serum resistance (75.9 ) contributed serum resistance EC958 using assay.          individual bacterial strains [32,33]. Furthermore, direct genetic case remaining 13 mutants, possible lack       evidence linking O-antigen biosynthesis serum resistance susceptibility human serum reflection assay,             available small number specific O-antigen types. suggesting survival serum mixed population          mind, detailed characterization O25b biosynthesis
million mutants different survival pure               genes performed using sequence comparison function
population carrying defective mutation.               prediction combination analysis LPS composition better mimic condition TraDIS library serum selection,             deduce role gene resistance serum.
competitive assay devised EC958 wild-type mixed                  Similar E. coli strains, O-antigen biosynthesis operon
equally mutant exposure serum                      located galF gnd genes EC958. Figure 5A
competitive index mutant measured. Using                    shows comparison EC958 O-antigen operon competitive assay, mutants significantly            equivalent operon K-12 strain MG1655 O25
attenuated compared wild-type EC958 strain (Table 2).                serotype E. coli strain E47a [32,55].  overall number validated susceptible mutants 46               Nucleotide sugar biosynthesis genes. genes 54 tested (85.2 ).                                                   encoding dTDP L-rhamnose biosynthesis enzymes highly
                                                                            conserved strains, consistent presence L-
Additional characteristics serum resistant mutants                       rhamnose O16 O25 antigen repeat unit expressed    hypothesized mechanism associated enhanced              MG1655 EC958, respectively [56–58]. dTDP L-
sensitivity human serum decreased membrane               rhamnose biosynthesis pathway starts D-glucose-1-phos-
integrity caused destabilization outer leaflet outer       phate produce dTDP L-rhamnose catalysis RmlA
membrane. order test  examined survival             make dTDP D-glucose), RmlB  make dTDP-4-dehydro-6-
54 mutants response outer membrane stresses  e. SDS)            deoxy D-glucose), RmlC  make dTDP-4-dehydro-6-deoxy-b-
osmotic potential  e. NaCl). total, 50.0  (27/54)               mannose) RmlD  make dTDP L-rhamnose), respectively.
mutants displayed enhanced sensitivity SDS 11.1  (6/54)              LPS gel analysis EC958 mutants lacking mutants displayed enhanced sensitivity NaCl (Table 2).          enzymes showed RmlC RmlD required comparative analysis phenotypes context serum            biosynthesis O-antigen mutation gene resulted sensitivity presented                                              cells lipid core (Figure 5C). contrary, 

PLOS Genetics | www.plosgenetics.org                                    5                      October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                         Serum Resistome E. coli ST131 Strain




Figure 4. Overview E. coli EC958 serum resistance genes. circular diagram depicts location 56 serum resistance genes E. coli EC958 genome. outer rings containing blue red arrows illustrate CDS serum resistance genes, respectively, forward reverse strand genome. inner red ring represents logFC control test samples CDS. insets
represent close look regions genome graphs showing location relative number mutant control (blue) test (red) samples.
doi:10.1371/journal.pgen.1003834.g004

LPS patterns rmlA rmlB mutants showed small                    polyhexamethylene biguanide suggested Wzx  known change intensity retained O-antigen chain                 RfbX) involved cellular stress responses [61]. length distribution, long chain length band.             contrast previous studies, wzx gene defined explained existence RffH RffG,               essential study (Figure 4, Table S1). isozymes RmlA RmlB, EC958. RffH RffG,                  explained fact Cm used select transposon able fully compensate RmlA RmlB resistance             mutants wzx mutants hypersensitive serum (Table 2). inability produce long chain             antibiotic. wzy O-antigen polymerase gene (EC958_2374) length O-antigen rmlA rmlB mutants crucial                 defined essential EC958 factor determining susceptibility human serum.              characterized. Mutation chain length regulator gene (wzz, rmlC mutant displayed altered sensitivity SDS,                  EC958_2368) showed non-modal distribution O-antigen
mutations rmlABCD did affect sensitivity NaCl (Table 2).           chain length LPS pattern (Figure 5C), observation
   O-antigen operon E47a set nucleotide                consistent previous study describing role gene [62].
sugar biosynthesis genes (fnlABC) biosynthesis UDP-N-             reduction long chain length O-antigen mutant acetyl L-fucosamine (UDP-FucNAc) UDP-N-acetyl D-                    likely account serum sensitivity shown assay
glucosamine (UDP-GlcNAc). Curiously, EC958 does                     (Table 2). genes operon genome.                 Glycosyltransferases genes. Glycosyltransferases (GTs)    O-antigen processing genes. O-antigen flippase (Wzx,                  required form glycosidic bonds sugars O-
EC958_2377) O-antigen polymerase (Wzy, EC958_2374)                       antigen repeat unit. 100,000 GTs EC958 highly similar corresponding genes                94 families (http://www.cazy.org). Based structure E47a. contrast, genes share low similarity               O25 repeat unit [63,64], predicted requirement 4 GTs corresponding genes MG1655. Mutation wzx gene                 EC958. Bioinformatic analysis (blastp) confirmed MG1655 results accumulation high levels UndPP-              4 GTs O-antigen operon: EC958_2371,
O unit cytoplasm [59] hypersensitivity                 EC958_2372, EC958_2375 EC958_2376. Surprisingly, antibiotics agents including nalidixic acid, tetracycline,         predicted GTs EC958 different mitomycin C hydrogen peroxide [60]. Transcriptional                      E47a. related different source L-
analyses MG1655 responses broad-spectrum biocide                   FucNAc EC958 lack fnlABC remains 

PLOS Genetics | www.plosgenetics.org                                     6                       October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                                    Serum Resistome E. coli ST131 Strain



 Table 2. Genes required serum resistance identified multiplexed TraDIS.


                                                                                                                                     SDS     NaCl
 EC958        Gene      Matched                                                                                                   MICd    MICd    COG
                                                                                                                               c
 locus_tag         MG1655         Product                                                             Serum           LPS       ( )     (M)     code

 EC958_0147   dnaJ      b0015          DnaJ chaperone                                                      1               WT        WT      WT      O
 EC958_0152   nhaA      b0019          Sodium/proton antiporter                                            0b              WT        WT      WT      P
 EC958_0260   acnB      b0118          aconitate hydratase 2/2-methylisocitrate dehydratase                1               WT        WT      WT      C
 EC958_0460   0460      -              -                                                                   3               X         WT      WT      -
 EC958_0461   0461      -              -                                                                   1b              X         WT      WT      TK
 EC958_0602   acrA      b0463          multidrug efflux                                             N             N       N     N     M
 EC958_0784   nagC      b0676          Transcriptional regulator, repressor N-acetylglucosamine         1               WT        WT      WT      KG
 EC958_0785   nagA      b0677          N-acetylglucosamine-6-phosphate deacetylase                         3               X         0.063   WT      G
 EC958_0806   pgm       b0688          Phosphoglucomutase                                                  4               X         0.016   WT      G
 EC958_0856   tolQ      b0737          membrane spanning protein Tol-Pal cell envelope complex          3               WT        0.031   WT      U
 EC958_0858   tolA      b0739          membrane anchored protein Tol-Pal cell envelope complex          3               WT        0.031   WT      M
 EC958_0859   tolB      b0740          periplasmic protein Tol-Pal cell envelope complex                0               WT        WT      WT      U
 EC958_0871   galE      b0759          UDP-galactose-4-epimerase                                           1               X         WT      WT      M
 EC958_1112   1112      -              -                                                                   1               X         WT      WT      -
 EC958_1114   1114      -              -                                                                   2               WT        WT      WT      -
 EC958_1897   lpp       b1677          murein lipoprotein                                                  6               WT        0.063   WT      M
 EC958_2368   wzz       b2027          regulator O-antigen chain length                                 1               X         WT      WT      M
 EC958_2371   2371      -              -                                                                   2               LA        0.063   WT      R
 EC958_2373   2373      -              -                                                                   N             N       N     N     E
 EC958_2378   rmlC      b2038          dTDP-4-deoxyrhamnose-3,5-epimerase                                  4               LA        0.063   WT      M
 EC958_2379   rmlA      b2039          glucose-1-phosphate thymidylyltransferase                           2               X         WT      WT      M
 EC958_2380   rmlD      b2040          dTDP-4-dehydrorhamnose reductase                                    4               LA        WT      WT      M
 EC958_2381   rmlB      b2041          dTDP-glucose 4,6 dehydratase                                        3               X         WT      WT      M
 EC958_2390   wcaI      b2050          glycosyl transferase involved colanic acid synthesis             0b              WT        WT      WT      M
                                                                                                               b
 EC958_2391   gmm       b2051          GDP-mannose mannosyl hydrolase                                      1               WT        WT      WT      F
 EC958_2394   wcaF      b2054          predicted acyl transferase                                          4               X         0.063   0.5     R
 EC958_2594   arnD      b2256          undecaprenyl phosphate-alpha-L-ara4FN deformylase                   2               WT        0.063   WT      G
 EC958_2596   arnE      b4544          ArnE/ArnF undecaprenyl-phosphate L-Ara4N flippase                 1               WT        WT      WT      P
 EC958_2597   arnF      b2258          ArnE/ArnF undecaprenyl-phosphate L-Ara4N flippase                 2               WT        WT      WT      -
 EC958_2652   dedA      b2317          conserved inner membrane protein                                    1b              WT        WT      WT      S
 EC958_2653   truA      b2318          pseudouridylate synthase                                          0b              WT        WT      WT      J
 EC958_2822   bamB      b2512          lipoprotein required OM biogenesis, BamABCD complex          3               WT        0.063   WT      S
 EC958_3571   nusA      b3169          transcription termination/antitermination L factor                  0b              WT        WT      WT      K
 EC958_3581   greA      b3181          transcript cleavage factor                                          2               WT        0.063   WT      K
 EC958_3621   sspA      b3229          stringent starvation protein                                      2               WT        0.063   WT      O
 EC958_4029   waaL      b3622          O-antigen ligase                                                    3               LA        0.063   WT      M
 EC958_4030   waaK      b3623          Lipopolysaccharide core biosynthesis; heptosyl transferase IV       3               LA        0.063   WT      M
 EC958_4032   waaY      b3625          Lipopolysaccharide core heptose (II) kinase                         5               LA        WT      ,0.3    T
 EC958_4033   waaJ      b3626          UDP-glucose:(glucosyl)LPS 1,2-glucosyltransferase                 2               LA        0.063   WT      M
 EC958_4034   waaI      b3627          UDP-D-glucose:(glucosyl)LPS 1,3-glucosyltransferase               5               X         0.063   0.5     M
 EC958_4035   waaB      b3628          UDP-D-galactose:(glucosyl)LPS-1, 6-D-galactosyltransferase          4               X         WT      WT      M
 EC958_4037   waaP      b3630          Lipopolysaccharide core heptose   kinase                          6               X         0.016   WT      -
 EC958_4038   waaG      b3631          Lipopolysaccharide glucosyltransferase                            6               X         0.016   0.5     M
 EC958_4050   pyrE      b3642          orotate phosphoribosyltransferase                                   2               WT        WT      WT      F
 EC958_4246   wecA      b3784          undecaprenyl-phosphate N-acetylglucosaminyl transferase           5               LA        0.063   WT      M
 EC958_4247   wzzE      b3785          ECA polysaccharide chain length modulation protein                  2               X         0.063   WT      M
 EC958_4252   wecD      b3790          TDP-fucosamine acetyltransferase                                    5               X         0.063   WT      -
 EC958_4253   wecE      b3791          TDP-4-oxo-6-deoxy-D-glucose transaminase                            2               WT        WT      WT      M




PLOS Genetics | www.plosgenetics.org                                         7                         October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                                             Serum Resistome E. coli ST131 Strain



 Table 2. Cont.


                                                                                                                                              SDS     NaCl
 EC958           Gene        Matched                                                                                                       MICd    MICd      COG
                                                                                                                                        c
 locus_tag              MG1655           Product                                                               Serum           LPS       ( )     (M)       code

 EC958_4254      wzxE        b3792            lipid III flippase                                                    0b              WT        WT      WT        R
 EC958_4255      wecF        b4481            TDP-Fuc4NAc:lipidIIFuc4NAc transferase                                1b              WT        0.063   WT        -
 EC958_4256      wzyE        b3793            ECA polysaccharide chain elongation                                   0b              WT        0.063   WT        -
 EC958_4322      rfaH        b3842            DNA-binding transcriptional antiterminator                            5               LA        0.016   ,0.3      K
 EC958_4336      dsbA        b3860            Protein disulfide oxidoreductase                                      1               WT        0.031   0.6       O
 EC958_4480      pgi         b4025            glucosephosphate isomerase                                            1b              WT        0.063   WT        G
                                                                                                                        b
 EC958_4658      miaA        b4171            D(2)-isopentenylpyrophosphate tRNA-adenosine transferase              0               WT        0.063   WT        J
 EC958_4725      fbp         b4232            fructose-1,6-bisphosphatase                                         3               WT        WT      WT        G

    Serum sensitivity shown 2log10 viable count difference t = 90 min t = 0 min. higher number sensitive mutant 
 b
   Serum sensitivity determined competitive assays: 0 means difference wild-type mutant; 1 means mutant  attenuated wild-type.
 c
  LPS patterns coded followed: WT, similar wild-type strain, change observed; LA, band lipid core observed; LA+1, lipid core band  band  X, changes observed, Supplementary Figure S3 band patterns.
 d
   wild-type (WT) MIC 0.8 M NaCl 0.125  SDS.
 doi:10.1371/journal.pgen.1003834.t002


investigated. O25 antigen structure known,                             sensitive human serum SDS  waaB attempted predict glycosidic link formed GT using                     waaY mutant), waaG, waaI waaY mutants
combination sequence similarity O-antigen structure                             displayed enhanced sensitivity NaCl (Table 2).
comparison previously described [64]; results                         ECA biosynthesis genes. Seven serum resistant candidate
shown Table 3 Figure 5B. able mutate                            genes ECA biosynthesis wec operon identified EC958_2371, EC958_2372 EC958_2375 defined                               TraDIS (Table 2). genes (wzxE wzyE) essential study. Analysis EC958_2371 mutant                          confirmed serum assays confer resistance changes
confirmed EC958_2371 required O-antigen biosynthe-                         observed LPS patterns mutants (Table 2,
sis (Figure 5C), serum resistance resistance SDS (Table 2).                     Figure S3). wzyE mutant  wzxE mutant) 
                                                                                        sensitive SDS (Table 2). LPS patterns serum resistance mechanisms affecting LPS                                     wzzE mutant revealed changes lipid core                                                                                        modulation O-antigen chain length (Figure S3). WzxE EC958                                                                                  previously shown preferentially form protein complex
   LPS gel analysis performed 54 defined mutants                         WzyE WzzE biosynthesis ECA Wzy identify genes contribute serum resistance affecting LPS                    Wzz [67].  results suggested WzzE (Figure S3). normal LPS pattern EC958 consists 12                            contribute chain length regulation O-antigen EC958.
bands including band representing lipid core                      WecA shown previously involved 11-band laddering pattern lipid core bound O-antigen                       biosynthesis O7, O18, O75, O111 antigen [68] polymers, followed approximately 6 bands long O-                      results indicate true O25b, explaining
antigen chain length (Figure 5C). addition 6 genes                           role WecA serum resistance EC958. wecD mutant
involved O-antigen biosynthesis mentioned  LPS                            highly sensitive serum, possessed LPS profile patterns 20 mutants altered comparison wild-type                         altered lipid core O-antigen, EC958; 6 mutants (waaLKYJ, wecA rfaH)                                displayed enhanced sensitivity SDS (Table 2, Figure S3).
produced lipid core (Table 2 Figure S3).                                       investigation required understand involvement    LPS core biosynthesis genes. genes involved                                  WecD lipid core O-antigen biosynthesis. Finally, biosynthesis LPS outer core EC958 share strong                               ECA biosynthesis mutants altered sensitivity NaCl.
similarity K-12 MG1655 (waaL waaGPBIJYK)                              genes. remaining 8 mutants altered LPS
[reviewed 65,66], suggesting LPS outer core structure                      patterns confirmed serum sensitive (Table 2). EC958 MG1655. expected                           included mutant, rfaH, produced lipid core, functions waaGBIJK MG1655, waaG mutant showed                            7 mutants different O-antigen patterns: hyxA (EC958_0460),
smallest size lipid core, indicating outer core                    hyxR (EC958_0461), nagA (N-acetylglucosamine-6-phosphate dea- linked lipid inner core. Mutations waaIJYK                    cetylase), pgm (phosphoglucomutase), galE (UDP-galactose-4-epim-
produced expected LPS pattern lipid core                         erase), EC958_1112 wcaF (predicted acetyltransferase 
mutations prevent linkage O-antigen outer core.                      volved colanic acid synthesis [69]). genes LPS waaB waaP mutants produced O-antigen laddering                          associated resistance additional stresses; EC958 rfaH
patterns containing abnormal lipidA-core band, indicating                      wcaF mutants sensitive SDS NaCl, nagA core structures changed, changes                         pgm mutants sensitive SDS (Table 2).
allow linking O-antigen outer core. WaaL responsible ligation O-antigen outer core                        Novel O-antigen chain length regulators
mutation gene resulted synthesis lipid core                       Mutation hyxA hyxR genes EC958 resulted O-antigen. EC958 waaL waaGPBIJYK mutants                               modulation O-antigen chain length (Figure 6B). EC958


PLOS Genetics | www.plosgenetics.org                                               8                          October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                            Serum Resistome E. coli ST131 Strain




Figure 5. Characterization O25b antigen genes EC958.   Comparison O-antigen cluster EC958 MG1655 (NC_000913) E47a (GU014554); genes green involved sugar biosynthesis, genes purple involved O-antigen processing genes orange
encode glycosyl transferase enzymes; genes black outline shown required serum resistance genes red outline defined essential. (B) Predicted function glycosyl transferases biosynthesis O25b repeat unit [57,58]. (C) LPS gels showing
changes O-antigen structures corresponding mutations gene.
doi:10.1371/journal.pgen.1003834.g005



hyxA mutant exhibited increased proportion O-antigen chain               Novel serum resistance mechanisms affecting LPS 2 6 units maximum number 3–5 units reduction                    major advantage genome approaches high chain length polymer. EC958 hyxR mutant                   TraDIS lies power discovery. 46 genes increased proportion O-antigen polymer 2–4 units.                 define serum resistome EC958, 21 (46 ) genes hyxA hyxR genes located pathogenicity island (PAI-X)              confirmed required serum resistance independent consisting 4 genes (fimX hyxRAB) previously described             altered LPS patterns (Table 2; Figure S3). function UPEC strain UTI89 [70]. hyxB gene (EC958_0459)                     genes ranged 10 COG functional categories included named upaB function autotransporter                 ‘Carbohydrate transport metabolism’ (4 genes), ‘Cell wall/
[71], prefer maintain nomenclature. island              membrane/envelope biogenesis’ (3), ‘Posttranslational modifica-
present  variations) 24 50 E. coli genomes         tion, protein turnover, chaperones’ (3) (Table 2). pathotypes (Figure 6A) current sequence data suggest              genes associated enhanced exclusive E. coli.                                                    sensitivity SDS enhanced NaCl sensitivity
   functional prediction hyxA,               (Table 2) report hyxA involvement serum resistance                       non-LPS genes required serum resistance, regulating O-antigen chain length. hyxR gene encodes                     notable lpp (logFC 210, log difference = 6) (Table 2). lpp
LuxR-like response regulator suppresses nitrosative stress            gene encodes abundant proteins E. coli response contributes intracellular survival macrophages              responsible stabilisation integrity bacterial cell regulating hmpA, encodes nitric oxide-detoxifying                   envelope [72]. Mutation lpp gene results formation flavohaemoglobin [70]. expression hyxR gene                      outer membrane blebs, leakage periplasmic enzyme ribonucle-
regulated bidirectional phase inversion promoter                ase, decreased growth rate media low ionic strength low
region upstream gene fimX, encodes tyrosine-like                osmolarity hypersensitive toxic compounds [73,74]. 
recombinase [70]. worth noting contribution             EC958 lpp mutant sensitive SDS, suggesting
hyxA serum resistance greater hyxR, demonstrated                decreased membrane integrity (Table 2). best 3-log reduction viability hyxA mutant compared                knowledge, study direct link Lpp hyxR mutant. serum sensitive phenotype hyxR                   serum resistance.
mutant observed mixed competition assays,                    set genes notable TraDIS analysis include
mutants did exhibit altered sensitivity SDS NaCl                     tolQAB, encode proteins (YbgC-YbgF-TolQ-
(Table 2).                                                                     R B-Pal) make Tol-Pal E. coli cell


PLOS Genetics | www.plosgenetics.org                                       9                       October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                                       Serum Resistome E. coli ST131 Strain



 Table 3. Summary E. coli EC958 O25b antigen biosynthesis genes.


                                                                                                    identities/ 
                                                                                            positives                          amino                                                                     amino acid
 Locus tag      Gene    acids     Similar protein                                                 overlap             predicted function

 EC958_2381     rmlB    361       dTDP-glucose 4,6-dehydratase [Escherichia coli NA114]           99/100/361          dTDP-glucose 4,6-dehydratase
                                  (YP_006139244)
 EC958_2380     rmlD    299       dTDP-4-dehydrorhamnose reductase [Escherichia                   100/100/299         dTDP-4-dehydrorhamnose reductase
                                  coli NA114] (YP_006139241)
 EC958_2379     rmlA    292       glucose-1-phosphate thymidylyltransferase                       100/100/292         glucose-1-phosphate thymidylyltransferase
                                  [Escherichia coli NA114] (YP_006139242)
 EC958_2378     rmlC    180       dTDP-4-dehydrorhamnose 3,5-epimerase                            99/99/180           dTDP-4-dehydrorhamnose 3,5-epimerase
                                  [Escherichia coli NA114] (YP_006139241)
 EC958_2377     wzx     419       O-antigen flippase Wzx [Escherichia coli E47a]                  95/98/149           O-antigen flippase
                                  (ADI43260)
 EC958_2376     wekA    321       putative glycosyl transferase family 2                          93/98/321           glycosyl transferase family 2;
                                  [Escherichia coli ABU83972] (ADN46883)                                              L-FucpNAc-(1-.3)-b-D-GlcpNAc
 EC958_2375     wekB    382       putative glycosyl transferase [Escherichia coli E47a]           93/97/382           glycosyl transferase family 4;
                                  (ADI43262)                                                                          b-D-Glcp-(1-.6)- D-Glcp
                                  glycosyl transferase WcmS [Escherichia                          39/59/372
                                  coli E1020-72, O158] (ADN43874)
 EC958_2374     wzy     405       O-antigen polymerase Wzy [Escherichia coli E47a]                92/95/346           O-antigen polymerase
                                  (ADI43263)
 EC958_2373     wbbJ    201       predicted lipopolysaccharide biosynthesis                       68/80/194           predicted lipopolysaccharide
                                  O-acetyl transferase [Escherichia coli str. K-12                                    biosynthesis O-acetyl transferase
                                  substr. MG1655] (NP_416537)
 EC958_2372     wbuH    366       Putative glycosyltransferase WbuH                               29/49/372           glycosyl transferase family 4;
                                  [Escherichia coli O4:K3:H5] (AAT85654)                                              D-Glcp-(1-.3)- L-FucpNAc
 EC958_2371     wbbL    263       Rhamnosyltransferase [Escherichia coli str. K-12                60/76/260           glycosyl transferase family 2;
                                  substr. MG1655] (P36667)                                                            Rhamnosyltransferase L-Rhap(1-.3 D-Glcp
 EC958_2370     gnd     468       6-phosphogluconate dehydrogenase                                100/100/468         6-phosphogluconate dehydrogenase
                                  [Escherichia coli NA114] (YP_006137974.1)
 EC958_2369     ugd     388       UDP-glucose-6-dehydrogenase [Escherichia coli NA114]            100/100/388         UDP-glucose-6-dehydrogenase
                                  (YP_006137975)
 EC958_2368     wzz     325       regulator length O-antigen component                   100/100/325         O-antigen chain length regulator
                                  lipopolysaccharide chain [Escherichia coli NA114]
                                  (YP_006137976)

 doi:10.1371/journal.pgen.1003834.t003


envelope. Tol-Pal responsible maintaining                           mutagenesis (Table 2). mechanism known confer
integrity outer membrane. TolQRA form inner                                     resistance polymixin B preventing binding lipid membrane complex TolQR necessary stability                            [Reviewed 78,79,80]. ArnD catalyzes deformylation step [75]. TolB, periplasmic protein, connects inner membrane                            generate UDP-L-Ara4N transported inner
complex peptidoglycan-associated lipoprotein, Pal,                         membrane ArnEF [79,81]. requirement ArnDEF anchored outer membrane [76]. study, mutation                         serum resistance indicates EC958 requires L-Ara4N modifi- tolA tolQ genes caused sensitivity human serum                             cation evade antimicrobial activity cationic peptides
increased sensitivity SDS, tolB mutant did                               present human serum. Interestingly, arnD mutation
(Table 2). results demonstrate Tol-Pal                             conferred sensitivity SDS (Table 2), suggest role
important resistance human serum,                              UDP-L-Ara4N maintaining membrane integrity. novel function important cell wall complex.                                      investigation needed understand ArnT, final enzyme
   BamB lipoprotein BamABCD complex.                             required transferring L-Ara4N residue 49-phosphate
Mutation bamB results increased outer membrane perme-                               group lipid core, identified TraDIS-defined
ability, enhancing sensitivity rifampin dramatically                          serum resistome.
reducing growth SDS novobiocin [77]. data showed                                  identified genes encoding catabolic enzymes mutation bamB gene EC958 resulted increased                             contributed serum resistance phenotype EC958 (gmm, pgi
sensitivity human serum SDS (Table 2).                                        fbp) confirmed role mutagenesis (Table 2).    TraDIS experiment indicated modification                          genes, pgi mutant displayed enhanced sensitivity SDS
lipid L-Ara4N important serum resistance.                            (Table 2). Gmm GDP-mannose mannosyl hydrolase capable (arnDEF) seven genes involved biosynthesis                              hydrolyzing GDP-mannose GDP-glucose [82]. attachment L-Ara4N lipid core identified                          enzyme contributes biosynthesis GDP-fucose, compo- serum resistome EC958 role confirmed                              nent colanic acid, possibly influencing concentration 

PLOS Genetics | www.plosgenetics.org                                                 10                         October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                      Serum Resistome E. coli ST131 Strain


GDP-mannose GDP-glucose cell regulating cell            mutant library. fact, OmpA inhibits serum-mediated killing
wall biosynthesis [82]. Pgi Fbp catalyze production        binding C4b-binding protein (C4BP) prevent D-fructose-6-phosphate b-D-glucose-6-phosphate fruc-              activation C3b classical complement pathway [85],
tose-1,6-bisphosphate, respectively [83,84]. D-fructose-6-phosphate        OmpA known released E. coli cells treated precursor biosynthesis UDP-GlcNAc, turn        serum [86]. mutant library, ompA mutants required peptidoglycan, lipid ECA biosynthesis.             accounted approximately 0.02  total bacterial cells, enzymes catalyse key reactions  disrupted,         hypothesized release OmpA 99.98  adversely affect downstream biosynthesis cell surface         cells, treated serum, provided OmpA trans components including colanic acid, peptidoglycan, lipid              complement ompA mutants. tested hypothesis mixing
ECA.                                                                       ompA mutant wild-type EC958 various ratios                                                                            showed ompA mutants protected serum ompA mutant protected serum killing                        killing proportion ompA mutants 15 
present low proportion mixed bacterial                           (Figure 7). result strongly suggests trans complemen-
population                                                                 tation OmpA prevents identification ompA serum
   chromosomal genes previously attributed serum             resistance gene assay.
resistance, gene identified TraDIS
screen ompA. examine constructed                 Complementation selected mutants restores serum
EC958 ompA mutant observed sensitive killing          resistance human serum (Figure 7). way explain discrepancy             demonstrate function non-LPS genes serum phenotype ompA mutant complemented              resistance, selected orphan genes (acnB, greA fbp) trans ompA-intact bacteria mixed population          belong operon perform genetic complementation.




Figure 6. Genetic context hyxA hyxR genes role O-antigen synthesis.   conserved location PAI-X containing
hyxAR genes E. coli genomes various pathotypes. (B) LPS pattern hyxA hyxR mutants complemented strains,
demonstrating role hyxA hyxR genes O-antigen chain length regulation. Red boxes highlight differences LPS patterns compared wild-type.
doi:10.1371/journal.pgen.1003834.g006


PLOS Genetics | www.plosgenetics.org                                  11                      October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                            Serum Resistome E. coli ST131 Strain

 experiments, selected gene amplified PCR,                 genes  mutated transposon insertion, cloned low copy number plasmid pSU2718G,                          prevent severely attenuate growth LB agar media
transformed respective mutant strain complementa-                 supplemented 30 mg/ml Cm 37uC. cut value tion. case, phenotype complemented strain                   determine gene essential defined intercept
exactly matched wild-type EC958 (Table 4). Taken                       distributions insertion index gene:  results confirm role acnB, greA fbp              exponential distribution representing essential genes serum resistance provide layer evidence support            gamma distribution representing non-essential genes [42]. use techniques TraDIS functional gene discovery.             means essential genes include genes                                                                                tolerate insertions severely attenuated input pool.
Discussion                                                                     315 essential genes, 64 genes transposon insertions,
                                                                               178 genes 1 5 transposon insertions 73 genes    rapid advancement new sequencing technologies                    5 transposon insertions (Table S1).
created novel opportunities interrogate biological systems                high density insertion sites achieved study previously possible. TraDIS described                  provided reliable data identification essential genes
method combined high-density mutagenesis Illumina                    EC958 genomes minimal probability false generation sequencing technology study essential genes             positive calls transposon insertion cold spots. S. Typhi conditional essential genes required                   identification essential genes previously performed
survival bile [42]. increased data output afforded              using approaches E. coli K-12 (strains MG1655 generation DNA sequencing particularly useful cost-                     W3110) [96,97]. Baba et al. generated null mutations lambda-
effective small bacterial genomes, presents technical
                                                                               red recombination 3985 E. coli W3110 genes  Keio library), bioinformatical challenges applications TraDIS
                                                                               unable mutate 303 candidate essential genes [97]. utilize low complexity DNA libraries. present                                                                                set essential genes consolidated manual literature
application modified version TraDIS amenable                                                                                review EcoGene website (www.ecogene.org), multiplexing using Illumina HiSeq 2000 platform,                                                                                reduced set 289 genes. 315 essential genes identified
demonstrate effectiveness using define essential gene
                                                                               EC958 study, 231 genes (73 ) matched previously
repertoire serum resistome multidrug resistant strain
                                                                               described EcoGene list (Table S1). 84 essential globally disseminated E. coli ST131 lineage.
                                                                               genes specific EC958,    multiplexed TraDIS protocol utilizes newly designed
                                                                               homologs MG1655 genome. contrast, 58 genes
custom oligonucleotide library enrichment step                                                                                previously identified essential E. coli K-12 Illumina library preparation protocol (Figure S1). oligonu-
                                                                               present EC958 identified analysis. majority cleotide incorporates Illumina sequencing primer-binding site
                                                                               essential genes EC958 conserved 91  genes transposon specific DNA fragments, enabling use                                                                                present 90  E. coli complete genomes available.
standard Illumina sequencing primer eliminating need                                                                                   study, provided layers evidence role design optimize sequencing primer new
                                                                               serum resistance gene: simultaneously assaying large
transposon sequence. 6-bp barcode immediately                                                                                mutant library generation defined mutants sequencing primer-binding site allows 12-sample multiplexing
                                                                               independent phenotypic testing.  using defined mutagen- lane. use 12 barcodes 6 nucleotides                                                                                esis able confirm role 46 56 genes identified
read 1 increased complexity library compared original TraDIS protocol, reducing data loss mis-
identification clusters [87,88].  number useable
reads sequencing runs low (15–20  total
reads). believe non-specific amplification enrichment
step main cause, optimization enrichment PCR conditions required. Similar approaches
combining transposon mutagenesis high-throughput sequenc-
ing (Tn-seq [45], INSeq [43], HITS [44]) used address different scientific questions, including identification essential genes genes associated enhanced fitness specific growth conditions [41,42,45], determination niche-
specific essential genes [43,44,89], identification genes associ-
ated tolerance various agents/conditions [42,90] applications reviewed [91,92]. terms insertion density, achieved 502,068 independent insertion sites density 1/10 bp  e. insertion 10 bp), comparable work Christen et al. (1/8 bp C. crescentus)
[41], Langridge et al. (1/13 bp Salmonella Typhi) [42]                  Figure 7. trans complementation wild-type EC958 protects
Barquist et al. (1/9 bp Salmonella Typhimurium) [46].                       ompA mutants serum killing. Wild-type EC958 EC958
   identification essential gene set single organism          ompA mutant mixed different ratios, exposed human serum challenging factors, including presence               90 minutes, EC958 ompA mutant examined transposon insertion cold spots  e. regions low transposon                sensitivity human serum (expressed 2log10 CFU difference
                                                                               time 90 time 0). red line indicates threshold insertion frequency), difficulty distinguishing mutations          strain considered resistant serum killing. EC958
prevent growth severely reduce growth rate, pre-               ompA mutant protected killing present percentage
existing gene duplications specific growth conditions used             15  mixed bacterial suspension. experiment [93–95]. study, define essential genes            doi:10.1371/journal.pgen.1003834.g007


PLOS Genetics | www.plosgenetics.org                                      12                       October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                                  Serum Resistome E. coli ST131 Strain



 Table 4. Complementation selected mutants.                                        available sequences GenBank database deducing
                                                                                      K type silico possible.
                                                                                         O25 antigen gene cluster characterized using
                           Phenotype                                                  sequence analysis, targeted mutation LPS profiling.  Strains
                                                                                      dTDP L-rhamnose biosynthesis genes (rmlCADB) required
                           Seruma           SDS ( )b         NaCl (M)b
                                                                                      serum resistance.  EC958 lacks biosynthesis genes
 EC958 (wild-type)         0                0.125            0.8                      UDP-FucNAc, component O25 antigen unit.  based  EC958DacnB                1                0.125            0.8                      cross reaction antiserum O25 antigen O25b
                                                                                      expressing cells, assume EC958 O-antigen
 EC958DacnB + pAcnB        0                0.125            0.8
                                                                                      repeat unit O25 determined previous studies [57,58],
 EC958DgreA                2                0.063            0.8
                                                                                      EC958 possess novel mechanism synthesis  EC958DgreA + pGreA        0                0.125            0.8                      uptake UDP-FucNAc.
 EC958Dfbp                 3                0.125            0.8                         additional surface antigens contribute serum
 EC958Dfbp + pFbp          0                0.125            0.8                      resistance EC958 enterobacterial common antigen                                                                                       colanic acid (M antigen). Mutations ECA biosynthesis genes
   Serum sensitivity shown 2log10 viable count difference            rendered EC958 susceptible serum. mutation  t = 90 min t = 0 min. higher number sensitive mutant
 
                                                                                      genes (wecA, wzzE wecD) affected LPS sensitivity  b
   Minimal inhibitory concentration (MIC) SDS ( ) NaCl (M).                    SDS, mutation wecE wecF did change LPS   doi:10.1371/journal.pgen.1003834.t004                                                wecF mutant sensitive SDS), suggesting ECA
                                                                                      involved serum resistance, indirectly role TraDIS serum resistance. best knowledge,                     membrane integrity. data suggest involvement represents large scale follow TraDIS data                     colanic acid serum resistance. genes encoding colanic
manner highlights effectiveness technique large-                    acid biosynthesis (wcaI, gmm wcaF) identified TraDIS.
scale functional genomics. study revealed trans                         Gmm likely involved biosynthesis colanic
complementation specific mutants occur large mutant                       acid [82], mutation wcaI gene did confer serum
library population, demonstrated findings ompA                      resistance. product wcaF predicted mutant. demonstrated complete complementation                              acetyltransferase [103] required colanic acid production [69].
mutants containing deletions acnB, greA fbp genes,                         EC958 wcaF mutant possessed altered LPS pattern corroborating novel role serum resistance independent                     reduced O-antigen (especially long chain length
LPS alterations. Finally, provided insight                        O-antigen) sensitive SDS high osmolarity.
mechanistic action serum resistance genes identified                        enhanced sensitivity EC958 wcaF mutant EC958 examining survival respective mutants                          explained number factors, including altered
outer membrane stresses affect antimicrobial access                          LPS, altered colonic acid reduced overall membrane integrity.
osmotic potential.                                                                       number genes identified contributed    search genetic determinants serum resistance                         serum resistance LPS-dependent manner. gene nagA
bacteria ongoing 1970s [98]. current                           encodes N-acetylglucosamine-6-phosphate deacetylase, enzyme
understanding mechanisms promote bacterial resis-                         important metabolism N-acetyl-D-glucosamine [104]. tance human serum include role surface structures                    catalyzes step producing UDP-GlcNAc, nucleotide
O antigens, K antigens, outer membrane proteins (OmpA),                           sugar required ECA, lipid peptidoglycan biosynthesis,
plasmid-encoded proteins (TraT, Iss) [37–39]; notably,                        deacetylating N-acetylglucosamine-6-phosphate glucos- mechanisms required resistance single                   amine-6-phosphate [Reviewed 105].  NagA bacterial strain [32,33]. study represents report                    solely responsible production UDP-GlcNAc simultaneously investigate entire serum resistome strain.                  glucosamine-6-phosphate obtained GlmS results demonstrated lipid core O25                           fructose-6-phosphate taken environment antigen crucial serum resistance EC958, K antigen                    ManXYZ [105].  LPS banding pattern nagA
does contribute serum resistance. 54 defined mutants                    mutant different parent strain  e. possessed
investigated, half changes LPS gel patterns,                      thicker second bands gel; Figure resulted serum sensitivity. contrast, K                       S3), suggesting enhanced sensitivity phenotype capsular biosynthesis genes identified TraDIS screen.                     associated predominantly shorter O antigen. result similar reported O75:K5 UPEC strain                       Pgm phosphoglucomutase catalyses reversible
GR-12, alterations O75 LPS affected serum resistance                         conversion glucose-1-phosphate glucose-6-phosphate, K5 null mutation [34]. likely,                   important step galactose maltose catabolism [106]. pgm strain-specific differences role O antigen K                       mutant phenotypes; defective swimming capsule serum resistance, reflects differences                swarming mobility [107], possesses aberrant (shorter make structures. example, previous analysis                     wider) cell morphology, sensitive detergents [108] stains
E. coli O4:K54:H5 blood isolate revealed K54 antigen                         blue iodine grown presence galactose [106].
contributes serum resistance O4 antigen [99].                        EC958 pgm mutant produced little length O-antigen; K antigens K1 K2 capsules                        majority LPS condensed band incomplete lipid
shown play important role serum resistance [100,101].                        core clear band lipid core plus unit O- K antigen expressed EC958 typed                               antigen. feature consistent high serum SDS
genomic analysis shows EC958 group 2 capsular gene                         sensitivity phenotypes observed mutant.
cluster conforms conserved structure group                           GalE studied enzyme catalyzes interconversion
[Reviewed 102].  region 2, encodes glycosyl-                         UDP-galactose UDP-glucose [Reviewed 109]. transferases specific K type, shares low similarity                     nucleotide sugars required colanic acid biosynthesis.


PLOS Genetics | www.plosgenetics.org                                             13                       October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                        Serum Resistome E. coli ST131 Strain


Furthermore, UDP-glucose used steps synthesize            25 mF 200V. Cells resuspended 1 mL SOC medium
LPS outer core (catalyzes WaaG, WaaI WaaJ). LPS                       incubated 37uC 2 hours, spread LB agar plates
patterns galE mutant exhibited band lipid           supplemented Cm 30 mg/mL. incubation overnight core, suggesting lipid core strain multiple           37uC, total number colonies estimated counting sizes. explained limiting effect UDP-glucose           proportion multiple plates. Chloramphenicol resistant steps involved incorporation outer core.        colonies resuspended sterilised LB broth using UDP-glucose synthesized GalU glucose-1-                  bacteriological spreader adding sterile glycerol 15 
phosphate [110], explain EC958 galE mutant                  total volume stored 280uC. batch mutants make LPS (Figure S3). Despite able make LPS,            contained estimated 32,000 180,000 mutants. final  galE mutant sensitive human serum.               library 1 million mutants created pooling 11 mutant sensitivity attributed effect galE mutation         batches, resulting cell suspension 261011 CFU/ml. LPS colanic acid remains determined.
   demonstrated successful application multiplexed            Transposon library screening human serum
TraDIS functional genomics study targeted E. coli EC958,               Freshly pooled human serum collected prototype strain globally disseminated multidrug              healthy individuals day experiment. milliliters resistant E. coli ST131 lineage. approach enabled             blood collected person centrifuged description essential gene set ExPEC strain.               4000 rpm 10 minutes collect serum. Approximately
work defined serum resistome E. coli EC958.             26108 viable mutants incubated 1 ml 50  freshly
comprehensive inventory E. coli EC958 genes contribute            pooled human serum LB broth 37uC 90 minutes. phenotype provides framework future characteriza-             control samples prepared way incubated
tion virulence genes ExPEC Gram-negative              inactivated serum (Millipore) instead fresh serum. pathogens cause systemic infection.                                     control test experiments performed duplicate.                                                                              cells washed twice sterile 16PBS remove serum,
Materials Methods                                                        transferred 100 ml LB broth allowed grow 37uC                                                                              250 rpm shaking 4 hours. genomic DNA Ethics statement                                                             extracted 5 ml culture using Qiagen 100-G genomic
   Approval collection human blood obtained              tips. University Queensland Medical Research Ethics Committee
(2008001123). subjects provided written informed consent.                Multiplexed TraDIS
                                                                                Genomic DNA standardized 3.6 mg volume Bacterial strains growth conditions                                      120 ml sheared Covaris S2 according    E. coli EC958 isolated urine patient presenting         Illumina TruSeq Enrichment gel-free method (TruSeq DNA community UTI Northwest region England               sample preparation v2 guide). subsequent steps DNA end
representative member UK epidemic strain (PFGE type),               repair, DNA end adenylation adapter ligation major pathogenic lineages causing UTI                  following Illumina TruSeq v2 instructions. adapter-ligated
United Kingdom [23]. EC958Dlac, contained mutation                fragments containing transposon insertion sites enriched lac operon, used competitive assays. strain           using transposon-specific indexing forward primer identical growth rate wild-type EC958. Strains routinely             Illumina reverse primer Index 1 (Table S5) 500 nM cultured 37uC solid liquid Luria Broth (LB) medium               reaction. 89 bp forward primer binds specifically miniTn5-
supplemented appropriate antibiotics (Cm 30 mg/ml                Cm transposon (25 bp) carries 64 bp overhang includes
gentamicin 20 mg/ml) unless indicated                              6 bp index sequence, 33 bp binding site Illumina read 1
                                                                             sequencing primer 23 bp P5 sequence binding Generation miniTn5-Cm mutant library                                      flowcell. enrichment step using KAPA Library
   miniTn5-Cm transposon containing Cm cassette flanked               Amplification kit (KAPA Biosystems) annealing temperature
Tn5 mosaic ends (sequence Epicenter) PCR amplified                  60uC 22 cycles. KAPA Library Quantification kit pKD3 plasmid DNA (NotI digested) using primers 2279 59-                 used measure concentration DNA fragments CTGTCTCTTATACACATCTcacgtcttgagcgattgtgtagg-39                            enriched library. libraries 12 samples pooled 2280      59-     CTGTCTCTTATACACATCTgacatgggaattagc-                        equimolar concentrations achieve cluster density 850 K/
catggtcc-39. PCR reactions performed using Phusion                  mm2 10 nM library pool loaded flowcell.
High-Fidelity DNA polymerase (New England BioLabs).                      12-plex pool loaded 3 lanes TruSeq v2 3 lanes
amplicon purified using QIAGEN MinElute PCR                          TruSeq v3 flowcells sequencing using 100 cycles, paired-
purification kit phosphorylated using T4 polynucle-             end protocol access reproducibility read quantity
otide kinase (New England BioLabs) subjected final                lanes flowcells. data samples (Figure 1A)
purification step. total 800 ng miniTn5-Cm             presented study. TraDIS sequence data transposon DNA incubated 8 ml reaction containing 4 ml             study deposited Sequence Read Archive (SRA) EZ-Tn5 transposase (Epicenter Biotechnologies) 37uC 1 h            BioProject number PRJNA189704. stored 220uC.
   Bacterial cells prepared electroporation previously           Analysis nucleotide sequence data
described [42]. Briefly, cells grown 26TY broth                  Sequence reads FASTQ files split according OD600 0.3–0.5, harvested washed times 0.56              6 bp index sequences combined 37 bp transposon-
volume 10  cold glycerol resuspended 1/                 specific sequence using fastx_barcode_splitter.pl (total length 10006 volume 10  cold glycerol kept ice. volume               43 bp barcodes, allowing 2 mismatches) (FASTX-Toolkit
60 ml cells mixed 0.2 ml transposomes electropo-             version 0.0.13, http://hannonlab.cshl.edu/fastx_toolkit/index.
rated 2 mm cuvette using BioRad GenePulser set 2.5 kV,             html). barcode matching reads trimmed 43 bp


PLOS Genetics | www.plosgenetics.org                                    14                      October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                           Serum Resistome E. coli ST131 Strain


barcode 59end 25 bp potential low quality 39               wild-type (EC958Dlac) mutant strains used. Viable
end, resulting high quality sequence reads 31 bp length                counts performed MacConkey agar, allowed used map EC958 chromosome (PRJEA61443)                      differentiation EC958Dlac (non-lactose fermenter) Maq version 0.7.1 [111]. Subsequent analysis steps                      mutant strains.
carried previously described [42] calculate number sequence reads (raw read counts) number different                    SDS NaCl sensitivity assays (MIC)
insertion sites gene, used estimate              MICs SDS NaCl determined broth
threshold identify essential genes. read counts insertion            microdilution method previously described [120]. used sites visualized using Artemis version 13.0 [112]. circular            concentrations SDS including 0.125 , 0.0625 , 0.031 ,
genome diagram generated CGView [113] linear                         0.016  0.008  LB. NaCl, range concentration
genetic comparison illustrated using Easyfig version 2.1 [114].             0.8 M, 0.6 M, 0.5 M, 0.4 M 0.3 M.

Statistical analyses                                                            LPS gel assay
   identified genes required survival human serum                    LPS extracted bacterial strains LPS patterns comparing differences read abundance gene                        determined Tricine-SDS Polyacrylamide gel electrophoresis inactivated serum control active serum test                     (TSDS-PAGE) visualized silver staining previously
samples using Bioconductor package edgeR (version 2.6.10)                   described [121,122].
[48]. raw read counts biological replicates treatment loaded edgeR package (version 2.6.12)
                                                                                Supporting Information
using R environment (version 2.15.1). Genes low read counts samples (essential genes) removed               Figure S1 Diagram demonstrating use custom primer analysis. composition bias sequence                    functional regions PCR enrichment transposon
library normalized using trimmed mean M value                        derived fragments.
(TMM) method [115]. used quantile-adjusted                          (PDF)
conditional maximum likelihood (qCML) negative binomial
models estimate dispersions (biological variation                Figure S2 Results edgeR analysis showing logFC genes
replicates) carry exact tests determining genes              highlighting genes satisfy stringent cut serum significantly lower read counts test samples compared               resistome. control samples [116,117]. Stringent criteria log fold-               (PDF)
change (logFC) #21 false discovery rate #0.001 chosen                  Figure S3 LPS patterns defined mutants generated define list significant genes investigation        study. LPS pattern wild-type strain EC958 (WT) used phenotypic assays.                                                           reference identify alteration LPS mutants.
                                                                                (PDF)
Molecular methods
                                                                                Table S1 Summary transposon insertions CDS    Chromosomal DNA purification, PCR DNA sequencing                                                                                 EC958 chromosome.
PCR products performed previously described [118].
                                                                                (XLSX)
Defined mutations using l-Red recombinase
method modifications [22,47]. brief, final PCR                 Table S2 Sequence comparison EC958 essential genes products fused amplified fragments contain-                 genes 50 E. coli complete genomes.
ing 500-bp homologous regions flanking gene                 (XLSX) Cm cassette pKD3 plasmid  Table S5 list                                                                                 Table S3 Essential genes unique EC958.
primers). fused PCR products electroporated EC958 harbouring gentamicin resistant plasmid carrying l-                 (XLSX)
Red recombinase gene. Mutants selected confirmed                  Table S4 Results edgeR analysis comparing read counts sequencing. Complementation cloning gene                  control test samples identify serum resistome. gentamicin resistant derivative pSU2718 [119]             (XLSX)
BamHI-XbaI cut sites (primers listed Table S5). construct transformed respective mutant induced                     Table S5 Primers used study.
using 1 mM IPTG phenotypic assays.                            (XLSX)

Serum resistance assay                                                          Acknowledgments
   Overnight bacterial cultures washed phosphate buffered               like thank Gemma Langridge, Keith Turner, Sabine Eckert,
saline (PBS) standardized OD600 0.8. Equal                    Daniel Turner, Philip Hugenholtz, Nicholas West Brian Forde volumes (50 mL) standardized cultures pooled human sera                  expert advice Leopold Parts statistical analysis R. mixed incubated 90 min 37uC  triplicates).
Viable counts performed estimate number bacterial                Author Contributions
cells prior serum treatment (t = 0 min) post serum
                                                                                Conceived designed experiments: MDP SS MT SAB MAS.
treatment (t = 90 min). E. coli MG1655 used control                 Performed experiments: MDP KMP SS SWL LPA MESA VMM. completely killed serum. Serum PBS samples                    Analyzed data: MDP DGM SAB MAS. Contributed reagents/
served sterility controls. Competitive serum resistance assays               materials/analysis tools: VMM MU SAB. Wrote paper: MDP SS performed manner, 50:50 mixture                  DGM MT MU SAB MAS.




PLOS Genetics | www.plosgenetics.org                                       15                      October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                                               Serum Resistome E. coli ST131 Strain




References
 1. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP,                        Caused Multidrug-Resistant Uropathogenic Escherichia coli ST131. J Infect
    et al. (2008) Intercontinental emergence Escherichia coli clone O25:H4-                    Dis 208(6):921–8.
    ST131 producing CTX-M-15. J Antimicrob Chemother 61: 273–281.                           25.   Floyd RV, Upton M, Hultgren SJ, Wray S, Burdyga TV, et al. (2012)
 2. Pitout JD, Gregson DB, Campbell L, Laupland KB (2009) Molecular                               Escherichia coli-mediated impairment ureteric contractility uropathogenic
    characteristics extended-spectrum-beta-lactamase-producing Escherichia                     E. coli specific. J Infect Dis 206: 1589–1596.
    coli isolates causing bacteremia Calgary Health Region 2000              26.   McCabe WR, Kaijser B, Olling S, Uwaydah M, Hanson LA (1978) Escherichia
    2007: emergence clone ST131 cause community-acquired infections.                   coli bacteremia: K O antigens serum sensitivity strains     Antimicrob Agents Chemother 53: 2846–2851.                                                    adults neonates. J Infect Dis 138: 33–41.
 3. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M (2010)                   27.   Martı´nez JL, Cercenado E, Pe´rez-Dı´az JC, Baquero F (1986) Multifactorial
    Escherichia coli sequence type ST131 major cause multidrug-                 determination systemic invasivity Escherichia coli. FEMS Microbiology
    resistant E. coli infections United States. Clin Infect Dis 51: 286–294.               Letters 37: 259–261.
 4. Peirano G, Pitout JD (2010) Molecular epidemiology Escherichia coli                  28.   Jacobson SH, O   ¨ Stenson C-G, Tullus K, Brauner (1992) Serum resistance     producing CTX-M beta-lactamases: worldwide emergence clone ST131                       Escherichia coli strains causing acute pyelonephritis bacteraemia. APMIS
    O25:H4. Int J Antimicrob Agents 35: 316–321.                                                  100: 147–153.
 5. Sidjabat  Derrington P, Nimmo GR, Paterson DL (2010) Escherichia coli                29.   Opal S, Cross  Gemski P (1982) K antigen serum sensitivity rough
    ST131 producing CTX-M-15 Australia. J Antimicrob Chemother 65: 1301–                       Escherichia coli. Infect Immun 37: 956–960.
    1303.                                                                                   30.   Feingold DS (1969) serum bactericidal reaction. IV. Phenotypic
 6. Rogers BA, Sidjabat  Paterson DL (2011) Escherichia coli O25b-ST131:                     conversion Escherichia coli serum-resistance serum-sensitivity     pandemic, multiresistant, community-associated strain. J Antimicrob Che-                      diphenylamine. J Infect Dis 120: 437–444.
    mother 66: 1–14.                                                                        31.   Gemski P, Cross  Sadoff JC (1980) K1 antigen-associated resistance  7. Ender PT, Gajanana D, Johnston B, Clabots C, Tamarkin FJ, et al. (2009)                       bactericidal activity serum. FEMS Microbiology Letters 9: 193–197.
    Transmission extended-spectrum-beta-lactamase-producing Escherichia               32.   Stawski G, Nielsen L, ØRskov F, ØRskov IDA (1990) Serum sensitivity     coli (sequence type ST131) strain father daughter resulting                  diversity Escherichia coli antigenic reference strains. APMIS 98: 828–838.
    septic shock Emphysematous pyelonephritis. J Clin Microbiol 47: 3780–               33.   Cross  Kim KS, Wright DC, Sadoff JC, Gemski P (1986) Role     3782.                                                                                         lipopolysaccharide capsule serum resistance bacteremic strains  8. Johnson JR, Anderson JT, Clabots C, Johnston B, Cooperstock M (2010)                          Escherichia coli. J Infect Dis 154: 497–503.
    household sharing fluoroquinolone-resistant Escherichia coli                34.   Burns SM, Hull SI (1998) Comparison loss serum resistance defined
    sequence type ST131 strain causing pediatric osteoarticular infection. Pediatr                lipopolysaccharide mutants acapsular mutant uropathogenic
    Infect Dis J 29: 473–475.                                                                     Escherichia coli O75:K5. Infect Immun 66: 4244–4253.
 9. Coque TM, Novais  Carattoli  Poirel L, Pitout J, et al. (2008)                      35.   Porat R, Mosseri R, Kaplan E, Johns MA, Shibolet S (1992) Distribution     Dissemination clonally related Escherichia coli strains expressing extend-                 polysaccharide chains lipopolysaccharide determine resistance     ed-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 14: 195–200.                            Escherichia coli bactericidal activity serum. J Infect Dis 165: 953–956.
10. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, et al. (2009)                 36.   Weiser JN, Gotschlich EC (1991) Outer membrane protein (OmpA)
    Epidemic clonal groups Escherichia coli cause antimicrobial-resistant              contributes serum resistance pathogenicity Escherichia coli K-1.
    urinary tract infections Canada, 2002 2004. Antimicrob Agents                           Infect Immun 59: 2252–2258.
    Chemother 53: 2733–2739.                                                                37.   Moll  Manning PA, Timmis KN (1980) Plasmid-determined resistance 11. Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, et al. (2013)                   serum bactericidal activity: major outer membrane protein, traT gene
    Abrupt Emergence Single Dominant Multidrug-Resistant Strain                           product, responsible plasmid-specified serum resistance Escherichia
    Escherichia coli. J Infect Dis 207: 919–928.                                                  coli. Infect Immun 28: 359–367.
12. Peirano G, Schreckenberger PC, Pitout JD (2011) Characteristics NDM-1-               38.   Montenegro MA, Bitter-Suermann D, Timmis JK, Aguero  Cabello FC, et
    producing Escherichia coli isolates belong successful virulent                al. (1985) traT gene sequences, serum resistance pathogenicity-related
    clone ST131. Antimicrob Agents Chemother 55: 2986–2988.                                       factors clinical isolates Escherichia coli gram-negative bacteria.
13. Morris D, Boyle F, Ludden C, Condon  Hale J, et al. (2011) Production                    J Gen Microbiol 131: 1511–1521.
    KPC-2 carbapenemase Escherichia coli clinical isolate belonging            39.   Smith HW (1974) search transmissible pathogenic characters invasive
    international ST131 clone. Antimicrob Agents Chemother 55: 4935–4936.                         strains Escherichia coli: discovery plasmid-controlled toxin 14. Morris D, McGarry E, Cotter M, Passet V, Lynch M, et al. (2012) Detection                  plasmid-controlled lethal character closely associated, identical, colicine
    OXA-48 carbapenemase pandemic clone Escherichia coli O25b:H4-                          V. J Gen Microbiol 83: 95–111.
    ST131 course investigation outbreak OXA-48-producing                 40.   Barondess JJ, Beckwith J (1995) bor gene phage lambda, involved serum
    Klebsiella pneumoniae. Antimicrob Agents Chemother 56: 4030–4031.                             resistance, encodes widely conserved outer membrane lipoprotein. J Bacteriol
15. Totsika M, Moriel DG, Idris  Rogers BA, Wurpel DJ, et al. (2012)                            177: 1247–1253.
    Uropathogenic Escherichia coli mediated urinary tract infection. Curr Drug              41.   Christen B, Abeliuk E, Collier JM, Kalogeraki VS, Passarelli B, et al. (2011)
    Targets 13: 1386–1399.                                                                        essential genome bacterium. Mol Syst Biol 7: 528.
16. Ulett GC, Totsika M, Schaale K, Carey AJ, Sweet MJ, et al. (2013)                       42.   Langridge GC, Phan MD, Turner DJ, Perkins TT, Parts L, et al. (2009)
    Uropathogenic Escherichia coli virulence innate immune responses                   Simultaneous assay Salmonella Typhi gene using million
    urinary tract infection. Curr Opin Microbiol 16: 100–107.                                     transposon mutants. Genome Res 19: 2308–2316.
17. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, et al. (2008)               43.   Goodman AL, McNulty NP, Zhao Y, Leip D, Mitra RD, et al. (2009)
    CTX-M-15-producing Escherichia coli diffusing clone belongs highly                   Identifying genetic determinants needed establish human gut symbiont     virulent B2 phylogenetic subgroup. J Antimicrob Chemother 61: 1024–1028.                      habitat. Cell Host Microbe 6: 279–289.
18. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E (2012)                         44.   Gawronski JD, Wong SM, Giannoukos G, Ward DV, Akerley BJ (2009)
    Virulence Escherichia coli clinical isolates murine sepsis model                   Tracking insertion mutants libraries deep sequencing genome-
    relation sequence type ST131 status, fluoroquinolone resistance,                       wide screen Haemophilus genes required lung. Proc Natl Acad
    virulence genotype. Infect Immun 80: 1554–1562.                                               Sci U S 106: 16422–16427.
19. Lavigne JP, Vergunst AC, Goret L, Sotto  Combescure C, et al. (2012)                  45.   van Opijnen T, Bodi KL, Camilli (2009) Tn-seq: high-throughput parallel
    Virulence potential genomic mapping worldwide clone Escherichia                    sequencing fitness genetic interaction studies microorganisms. Nat
    coli ST131. PLoS 7: e34294.                                                               Methods 6: 767–772.
20. Gibreel TM, Dodgson AR, Cheesbrough J, Bolton FJ, Fox AJ, et al. (2012)                 46.   Barquist L, Langridge GC, Turner DJ, Phan MD, Turner AK, et al. (2013)     High metabolic potential contribute success ST131 uropatho-                     comparison dense transposon insertion libraries Salmonella serovars
    genic Escherichia coli. J Clin Microbiol 50: 3202–3207.                                       Typhi Typhimurium. Nucleic Acids Res 41(8):4549–64.
21. Vimont S, Boyd  Bleibtreu  Bens M, Goujon JM, et al. (2012) CTX-                47.   Datsenko KA, Wanner BL (2000) step inactivation chromosomal genes
    M-15-producing Escherichia coli clone O25b: H4-ST131 high intestine                       Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S 97:
    colonization urinary tract infection abilities. PLoS 7: e46547.                       6640–6645.
22. Totsika M, Beatson SA, Sarkar S, Phan MD, Petty NK, et al. (2011) Insights              48.   Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: Bioconductor
    Multidrug Resistant Escherichia coli Pathogen Globally                          package differential expression analysis digital gene expression data.
    Disseminated ST131 Lineage: Genome Analysis Virulence Mechanisms.                         Bioinformatics 26: 139–140.
    PLoS 6: e26578.                                                                     49.   Whang HY, Neter E (1973) Production common enterobacterial antigen 23. Lau SH, Kaufmann  Livermore DM, Woodford N, Willshaw GA, et al.                            members family Enterobacteriaceae. Experientia 29: 96–97.
    (2008) UK epidemic Escherichia coli strains E, CTX-M-15 beta-                    50.   Makela PH, Mayer H (1976) Enterobacterial common antigen. Bacteriol Rev
    lactamase, belong international O25:H4-ST131 clone. J Antimicrob                   40: 591–632.
    Chemother 62: 1241–1244.                                                                51.   Beutin L, Manning PA, Achtman M, Willetts N (1981) sfrA sfrB products
24. Totsika M, Kostakioti M, Hannan TJ, Upton M, Beatson SA, et al. (2013)                      Escherichia coli K-12 transcriptional control factors. J Bacteriol 145:
    FimH Inhibitor Prevents Acute Bladder Infection Treats Chronic Cystitis                   840–844.



PLOS Genetics | www.plosgenetics.org                                                   16                            October 2013 | Volume 9 | Issue 10 | e1003834
                                                                                                                              Serum Resistome E. coli ST131 Strain


52. Bailey MJ, Hughes C, Koronakis V (1996) Increased distal gene transcription              82. Frick DN, Townsend BD, Bessman MJ (1995) novel GDP-mannose
    elongation factor RfaH, specialized homologue NusG. Mol                          mannosyl hydrolase shares homology MutT family enzymes. J Biol
    Microbiol 22: 729–737.                                                                       Chem 270: 24086–24091.
53. Nagy G, Dobrindt U, Schneider G, Khan  Hacker J, et al. (2002) Loss                83. Fraenkel DG, Levisohn SR (1967) Glucose gluconate metabolism     regulatory protein RfaH attenuates virulence uropathogenic Escherichia                    Escherichia coli mutant lacking phosphoglucose isomerase. J Bacteriol 93:
    coli. Infect Immun 70: 4406–4413.                                                            1571–1578.
54. Nagy G, Dobrindt U, Grozdanov L, Hacker J, Emody L (2005) Transcriptional                84. Fraenkel DG, Horecker BL (1965) Fructose-1, 6-diphosphatase acid
    regulation RfaH contributes intestinal colonization Escherichia                hexose phosphatase Escherichia coli. J Bacteriol 90: 837–842.
    coli. FEMS Microbiol Lett 244: 173–180.                                                  85. Prasadarao NV, Blom  Villoutreix BO, Linsangan LC (2002) novel
55. Wang Q, Wang S, Beutin L, Cao B, Feng L, et al. (2010) Development                      interaction outer membrane protein C4b binding protein mediates
    DNA microarray detection serotyping enterotoxigenic Escherichia                   serum resistance Escherichia coli K1. J Immunol 169: 6352–6360.
    coli. J Clin Microbiol 48: 2066–2074.                                                    86. Hellman J, Loiselle PM, Tehan MM, Allaire JE, Boyle LA, et al. (2000) Outer
56. Stevenson G, Neal B, Liu D, Hobbs M, Packer NH, et al. (1994) Structure                   membrane protein  peptidoglycan-associated lipoprotein, murein
    O antigen Escherichia coli K-12 sequence rfb gene cluster.             lipoprotein released Escherichia coli bacteria serum. Infect Immun
    J Bacteriol 176: 4144–4156.                                                                   68: 2566–2572.
57. Kenne L, Lindberg B, Madden JK, Lindberg AA, Gemski P, Jr. (1983)                        87. Kircher M, Heyn P, Kelso J (2011) Addressing challenges production
    Structural studies Escherichia coli O-antigen 25. Carbohydr Res 122:                  analysis illumina sequencing data. BMC Genomics 12: 382.
    249–256.                                                                                 88. Krueger F, Andrews SR, Osborne CS (2011) Large scale loss data low-
58. Fundin J, Weintraub  Xu J-G, Widmalm G (2003) NMR analysis O-                       diversity illumina sequencing libraries recovered deferred cluster
    antigen polysaccharide Escherichia coli strain F171. Magnetic Resonance                 calling. PLoS 6: e16607.
    Chemistry 41: 202–205.                                                                89. Crimmins GT, Mohammadi S, Green ER, Bergman MA, Isberg RR, et al.
59. Liu D, Cole RA, Reeves PR (1996) O-antigen processing function Wzx                    (2012) Identification MrtAB, ABC transporter specifically required     (RfbX): promising candidate O-unit flippase. J Bacteriol 178: 2102–2107.               Yersinia pseudotuberculosis colonize mesenteric lymph nodes. PLoS
60. Han X, Dorsey-Oresto  Malik M, Wang JY, Drlica K, et al. (2010)                            Pathog 8: e1002828.
    Escherichia coli genes reduce lethal effects stress. BMC Microbiol           90. Gallagher LA, Shendure J, Manoil C (2011) Genome-scale identification     10: 35.                                                                                      resistance functions Pseudomonas aeruginosa using Tn-seq. MBio 2:
61. Allen MJ, White GF, Morby AP (2006) response Escherichia coli                      e00315–00310.
    exposure biocide polyhexamethylene biguanide. Microbiology 152: 989–              91. van Opijnen T, Camilli (2013) Transposon insertion sequencing: new tool
    1000.                                                                                        systems-level analysis microorganisms. Nat Rev Microbiol 11: 435–442.
62. Franco AV, Liu D, Reeves PR (1998) wzz (cld) protein Escherichia coli:            92. Barquist L, Boinett CJ, Cain AK (2013) Approaches querying bacterial
    amino acid sequence variation determines O-antigen chain length specificity.                 genomes transposon-insertion sequencing. RNA Biol 10: 1161–9.
    J Bacteriol 180: 2670–2675.                                                              93. Koonin EV (2003) Comparative genomics, minimal gene-sets 63. Stenutz R, Weintraub  Widmalm G (2006) structures Escherichia coli                  universal common ancestor. Nat Rev Microbiol 1: 127–136.
    O-polysaccharide antigens. FEMS Microbiol Rev 30: 382–403.                               94. Fang G, Rocha E, Danchin (2005) essential nonessential genes? Mol
64. Lundborg M, Modhukur V, Widmalm G (2010) Glycosyltransferase functions                       Biol Evol 22: 2147–2156.
    E. coli O-antigens. Glycobiology 20: 366–368.                                         95. Gerdes S, Edwards R, Kubal M, Fonstein M, Stevens R, et al. (2006) Essential
65. Schnaitman CA, Klena JD (1993) Genetics lipopolysaccharide biosynthesis                   genes metabolic maps. Curr Opin Biotechnol 17: 448–456.
    enteric bacteria. Microbiol Rev 57: 655–682.                                          96. Gerdes SY, Scholle MD, Campbell JW, Balazsi G, Ravasz E, et al. (2003)
66. Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev                         Experimental determination level analysis essential genes     Biochem 71: 635–700.                                                                         Escherichia coli MG1655. J Bacteriol 185: 5673–5684.
67. Marolda CL, Tatar LD, Alaimo C, Aebi M, Valvano MA (2006) Interplay                   97. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, et al. (2006) Construction
    Wzx translocase corresponding polymerase chain length                        Escherichia coli K-12 frame, single-gene knockout mutants: Keio
    regulator proteins translocation periplasmic assembly lipopoly-                collection. Mol Syst Biol 2: 2006 0008.
    saccharide o antigen. J Bacteriol 188: 5124–5135.                                        98. Taylor PW (1975) Genetical studies serum resistance Escherichia coli.
68. Alexander DC, Valvano MA (1994) Role rfe gene biosynthesis                  J Gen Microbiol 89: 57–66.
    Escherichia coli O7-specific lipopolysaccharide O-specific                 99. Russo TA, Sharma G, Brown CR, Campagnari AA (1995) Loss O4
    polysaccharides containing N-acetylglucosamine. J Bacteriol 176: 7079–7084.                  antigen moiety lipopolysaccharide extraintestinal isolate 69. Danese PN, Pratt LA, Kolter R (2000) Exopolysaccharide production                         Escherichia coli minor effects serum sensitivity virulence     required development Escherichia coli K-12 biofilm architecture.                      vivo. Infect Immun 63: 1263–1269.
    J Bacteriol 182: 3593–3596.                                                             100. Buckles EL, Wang X, Lane MC, Lockatell CV, Johnson  et al. (2009) Role
70. Bateman SL, Seed PC (2012) Epigenetic regulation nitrosative stress                   K2 capsule Escherichia coli urinary tract infection serum
    response intracellular macrophage survival extraintestinal pathogenic                 resistance. J Infect Dis 199: 1689–1697.
    Escherichia coli. Mol Microbiol 83: 908–925.                                            101. Leying H, Suerbaum S, Kroll HP, Stahl D, Opferkuch W (1990) capsular
71. Allsopp LP, Beloin C, Ulett GC, Valle J, Totsika M, et al. (2012) Molecular                  polysaccharide major determinant serum resistance K-1-positive blood
    characterization UpaB UpaC, new autotransporter proteins                       culture isolates Escherichia coli. Infect Immun 58: 222–227.
    uropathogenic Escherichia coli CFT073. Infect Immun 80: 321–332.                        102. Whitfield C (2006) Biosynthesis assembly capsular polysaccharides 72. Keseler IM, Collado-Vides J, Santos-Zavaleta  Peralta-Gil M, Gama-Castro                   Escherichia coli. Annu Rev Biochem 75: 39–68.
    S, et al. (2011) EcoCyc: comprehensive database Escherichia coli biology.          103. Stevenson G, Andrianopoulos K, Hobbs M, Reeves PR (1996) Organization     Nucleic Acids Res 39: D583–590.                                                              Escherichia coli K-12 gene cluster responsible production 73. Yem DW, Wu HC (1978) Physiological characterization Escherichia coli                   extracellular polysaccharide colanic acid. J Bacteriol 178: 4885–4893.
    mutant altered structure murein lipoprotein. J Bacteriol 133: 1419–           104. White RJ (1968) Control amino sugar metabolism Escherichia coli     1426.                                                                                        isolation mutants unable degrade amino sugars. Biochem J 106: 847–858.
74. Vadillo-Rodriguez V, Schooling SR, Dutcher JR(2009) situ characterization            105. Park JT, Uehara T (2008) bacteria consume exoskeletons
    differences viscoelastic response individual gram-negative                  (turnover recycling cell wall peptidoglycan). Microbiol Mol Biol Rev 72:
    gram-positive bacterial cells. J Bacteriol 191: 5518–5525.                                   211–227.
75. Cascales E, Lloubes R, Sturgis JN (2001) TolQ-TolR proteins energize                106. Adhya S, Schwartz M (1971) Phosphoglucomutase mutants Escherichia coli
    TolA share homologies flagellar motor proteins MotA-MotB. Mol                   K-12. J Bacteriol 108: 621–626.
    Microbiol 42: 795–807.                                                                  107. Inoue T, Shingaki R, Hirose S, Waki K, Mori H, et al. (2007) Genome-wide
76. Walburger  Lazdunski C, Corda Y (2002) Tol/Pal function                         screening genes required swarming motility Escherichia coli K-12.
    requires interaction C-terminal domain TolA N-                     J Bacteriol 189: 950–957.
    terminal domain TolB. Mol Microbiol 44: 695–708.                                     108. Lu M, Kleckner N (1994) Molecular cloning characterization pgm
77. Onufryk C, Crouch ML, Fang FC, Gross CA (2005) Characterization                       gene encoding phosphoglucomutase Escherichia coli. J Bacteriol 176: 5847–
    lipoproteins sigmaE regulon. J Bacteriol 187: 4552–4561.                              5851.
78. Nikaido H, Vaara M (1985) Molecular basis bacterial outer membrane                   109. Frey PA (1996) Leloir pathway: mechanistic imperative     permeability. Microbiol Rev 49: 1–32.                                                        enzymes change stereochemical configuration single carbon 79. Yan  Guan  Raetz CR (2007) undecaprenyl phosphate-aminoarabinose                      galactose. FASEB J 10: 461–470.
    flippase required polymyxin resistance Escherichia coli. J Biol Chem 282:        110. Weissborn AC, Liu Q, Rumley MK, Kennedy EP (1994) UTP: alpha-D-
    36077–36089.                                                                                 glucose-1-phosphate uridylyltransferase Escherichia coli: isolation DNA
80. Trent MS, Ribeiro AA, Doerrler WT, Lin S, Cotter RJ, et al. (2001)                           sequence galU gene purification enzyme. J Bacteriol 176:
    Accumulation 